Chris Hafner brings over 14 years of clinical and regulatory affairs medical device experience across various therapeutic areas including ophthalmology, orthopedics, hematology, neurology, and cardiology. His last 10 years were spent in the start-up arena, with successful acquisitions at ClarVista Medical (Alcon), Ellipse Technologies (NuVasive), and AqueSys (Allergan). Chris graduated with baccalaureate degrees in Physiology and Psychology from the University of Minnesota – Twin Cities.